Joyce Meghan V.
SEC Form 4 insider trading activity
Joyce Meghan V. has filed 4 SEC Form 4 filings (9 transaction rows) across 2 companies, including GH, SAM, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Jun 22, 2026.
On the most recent filing, Joyce Meghan V. is listed as Director at Guardant Health, Inc. Inside the rolling window, Joyce Meghan V. reported no open-market purchases and 1 open-market sale totaling $1.3M in GH.
Companies traded
Other insiders at GH
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.3M
reported sales (SEC code S)
Companies
2
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Sep 2, 2025 | GH | Sale | $7K |
Frequently asked questions
How many SEC Form 4 filings has Joyce Meghan V. made?
Joyce Meghan V. has filed 4 SEC Form 4 filings (9 transaction rows) across 2 companies, including GH, SAM since 2025.
Which companies does Joyce Meghan V. trade?
Joyce Meghan V. has filed SEC Form 4 disclosures for 2 companies, including GH, SAM.
When was Joyce Meghan V.'s most recent SEC Form 4 filing?
Joyce Meghan V.'s most recent SEC Form 4 filing on Tracefour is dated Jun 22, 2026.
What is Joyce Meghan V.'s total buy and sell value in the current window?
Inside the rolling retention window, Joyce Meghan V. bought $0 and sold $1.3M based on SEC Form 4 filings.
What was Joyce Meghan V.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 10,000 GH shares on 2026-06-03, worth $1.3M, per SEC Form 4 filings.